{"id":88318,"date":"2026-05-12T08:25:44","date_gmt":"2026-05-12T14:25:44","guid":{"rendered":"https:\/\/trimrx.com\/blog\/fat-burning-shot-vermont-glp1-weight-loss-injections\/"},"modified":"2026-05-12T08:25:44","modified_gmt":"2026-05-12T14:25:44","slug":"fat-burning-shot-vermont-glp1-weight-loss-injections","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/fat-burning-shot-vermont-glp1-weight-loss-injections\/","title":{"rendered":"Fat Burning Shot Vermont \u2014 GLP-1 Weight Loss Injections"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Fat Burning Shot Vermont \u2014 GLP-1 Weight Loss Injections<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Vermont residents now have access to the same medically supervised weight loss injections previously reserved for specialty clinics in major metro areas. A 2023 analysis published in The Lancet found GLP-1 medications (semaglutide, tirzepatide) produce mean weight loss of 15\u201322% over 68 weeks. Outcomes that traditional calorie restriction achieves in fewer than 8% of patients long-term. The constraint wasn&#39;t efficacy; it was access. Insurance denials, six-month waitlists, and in-person visit requirements meant most Vermonters who qualified never started treatment.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has worked with patients across Burlington, Rutland, and Essex Junction navigating exactly this gap. The difference between starting treatment this month versus waiting six months for an in-person slot is measurable. Both in metabolic outcomes and in the compounding psychological toll of repeated diet failures while knowing effective pharmacological treatment exists but remains out of reach.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What is a fat burning shot and how does it work for weight loss?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">A &#39;fat burning shot&#39; refers to weekly subcutaneous injections of GLP-1 receptor agonists. Medications like semaglutide (Wegovy, Ozempic) or tirzepatide (Mounjaro, Zepbound) that mimic the incretin hormone glucagon-like peptide-1. These medications bind to GLP-1 receptors in the hypothalamus, suppressing appetite signaling, while simultaneously slowing gastric emptying to extend postprandial satiety. Clinical trials show 14.9% mean body weight reduction with semaglutide 2.4mg weekly and 20.9% with tirzepatide 15mg weekly. Outcomes dieting alone rarely sustains past 12 months.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Yes, fat burning shot Vermont programs deliver the same pharmaceutical-grade GLP-1 medications used in landmark clinical trials. But the mechanism isn&#39;t &#39;burning fat&#39; in the metabolic sense most people imagine. GLP-1 receptor agonists don&#39;t increase thermogenesis or oxidise stored triglycerides directly. Instead, they interrupt the hormonal cascade that drives hunger after weight loss: elevated ghrelin, suppressed leptin, and reduced resting energy expenditure. When you lose weight through caloric restriction alone, your body adapts by making you hungrier and more metabolically efficient. A survival mechanism that makes sustained weight loss physiologically difficult. GLP-1 medications counteract that adaptation, allowing patients to maintain a caloric deficit without the relentless hunger rebound that typically occurs 8\u201316 weeks into traditional dieting. This article covers how Vermont residents access these medications through telehealth platforms, what clinical outcomes to expect at each dose tier, and the preparation errors that negate efficacy entirely.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">How Fat Burning Shot Vermont Programs Differ from Traditional Weight Loss<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Traditional weight loss in Vermont. Whether through in-person dietitian consultations, commercial programs, or self-directed calorie tracking. Relies on sustained caloric deficit without pharmacological intervention. The physiological problem: your body doesn&#39;t distinguish voluntary restriction from famine. After 10\u201315% weight loss, compensatory mechanisms activate: ghrelin (the hunger hormone) rises 20\u201330% above baseline, leptin (the satiety hormone) drops proportionally, and non-exercise activity thermogenesis (NEAT) decreases by 200\u2013400 calories daily. You feel hungrier while burning fewer calories at rest. A metabolic state that makes regaining lost weight nearly inevitable without continued vigilant restriction.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Fat burning shot Vermont protocols using semaglutide or tirzepatide interrupt this cycle at the receptor level. GLP-1 agonists bind to GLP-1 receptors in the arcuate nucleus of the hypothalamus, directly modulating appetite signaling independent of caloric intake. They also slow gastric emptying, meaning food stays in the stomach longer. Extending the window during which satiety hormones like cholecystokinin (CCK) and peptide YY (PYY) remain elevated. The STEP-1 trial published in the New England Journal of Medicine demonstrated that patients on semaglutide 2.4mg weekly lost 14.9% of body weight over 68 weeks versus 2.4% in the placebo group, despite both groups receiving identical lifestyle counseling. The medication didn&#39;t replace dietary structure; it made adherence to that structure physiologically sustainable.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">TrimRx provides medically supervised fat burning shot Vermont treatment through a fully remote telehealth platform. Licensed Vermont prescribers evaluate eligibility, write prescriptions for compounded semaglutide or tirzepatide, and coordinate shipment to any Vermont address within 48 hours. Patients in Montpelier, South Burlington, and St. Albans receive the same pharmaceutical-grade medications used in clinical trials. Prepared by FDA-registered 503B outsourcing facilities under USP &lt;797&gt; sterile compounding standards. Our experience shows the barrier to starting treatment is rarely medical contraindication; it&#39;s navigating insurance denials, scheduling delays, and the opacity of compounding pharmacy networks without guidance.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What to Expect: Dosing, Timeline, and Realistic Outcomes<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">GLP-1 medications follow a titration schedule designed to allow receptor downregulation to match increasing doses. Starting too high causes intolerable nausea that leads to discontinuation. Standard semaglutide escalation begins at 0.25mg weekly for four weeks, increasing to 0.5mg, then 1.0mg, 1.7mg, and finally 2.4mg (the therapeutic dose) over 20 weeks. Tirzepatide follows a similar pattern: 2.5mg weekly for four weeks, then 5mg, 7.5mg, 10mg, 12.5mg, and 15mg over 24 weeks. Patients notice appetite suppression within the first week at starting dose, but meaningful weight reduction. Defined as 5% or more of body weight. Typically requires 8\u201312 weeks at therapeutic dose.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Clinical trial data provides realistic benchmarks. The SURMOUNT-1 Phase 3 trial found tirzepatide 15mg produced mean body weight reduction of 20.9% at 72 weeks versus 3.1% placebo. Semaglutide 2.4mg in the STEP-1 trial achieved 14.9% at 68 weeks. Individual variation is significant: approximately 35% of patients are &#39;super responders&#39; who lose more than 20% of body weight, while 10\u201315% lose less than 5% despite adherence. Response predictors include baseline insulin resistance (higher resistance predicts better response), concurrent dietary structure (patients maintaining structured meal timing lose 2\u20133\u00d7 more than those relying on the medication alone), and gastrointestinal tolerance (patients who can&#39;t tolerate therapeutic doses plateau at lower weight loss).<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Fat burning shot Vermont patients should expect gastrointestinal side effects. Nausea, vomiting, diarrhea, constipation. In 30\u201345% of cases during dose escalation. These effects peak within 48 hours of each dose increase and typically resolve within 4\u20138 weeks as GLP-1 receptor density in the gut adjusts. Mitigation strategies: eat smaller meals (300\u2013400 calories per sitting rather than 700+), avoid high-fat foods in the first 12 hours post-injection, stay upright for two hours after eating, and slow the titration schedule if symptoms are severe. Serious adverse events. Pancreatitis, gallbladder disease, and thyroid C-cell tumors. Are rare but documented; patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) should not use GLP-1 agonists.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Fat Burning Shot Vermont: Comparison of GLP-1 Medications<\/h2>\n<div style=\"overflow-x:auto;-webkit-overflow-scrolling:touch;width:100%;margin:1.5em 0;\">\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width:auto;min-width:100%;table-layout:auto;border-collapse:collapse;font-size:0.95em;box-shadow:0 2px 4px rgba(0,0,0,0.1);\" style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color:#f8f9fa;border-bottom:2px solid #dee2e6;\" style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Medication<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Active Compound<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Typical Weekly Dose<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Mean Weight Loss (Clinical Trials)<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Injection Frequency<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Unique Mechanism<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Professional Assessment<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Semaglutide (Wegovy)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">GLP-1 receptor agonist<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">2.4mg<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">14.9% at 68 weeks (STEP-1)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Once weekly<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Pure GLP-1 agonism. Hypothalamic appetite suppression + gastric emptying delay<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Best-studied option with longest safety data; ideal for patients prioritising established evidence base over maximal efficacy<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Tirzepatide (Zepbound)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Dual GLP-1\/GIP receptor agonist<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">10\u201315mg<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">20.9% at 72 weeks (SURMOUNT-1)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Once weekly<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Dual incretin action. GIP component enhances insulin sensitivity and may reduce GI side effects<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Highest weight loss in head-to-head trials; some evidence suggests better GI tolerability than semaglutide at equivalent efficacy<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Liraglutide (Saxenda)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">GLP-1 receptor agonist<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">3.0mg daily<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">8.0% at 56 weeks (SCALE)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Daily injection<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Shorter half-life requires daily dosing; lower peak plasma levels may reduce nausea<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Rarely used for weight loss in 2026. Weekly options with superior outcomes have replaced it in clinical practice<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Compounded Semaglutide<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">GLP-1 receptor agonist (503B compounded)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">2.0\u20132.5mg<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not independently trialed. Same molecule as Wegovy<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Once weekly<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Identical mechanism to brand-name semaglutide but prepared by compounding pharmacies under 503B regulations<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">60\u201385% less expensive than Wegovy; allows access during brand shortages but lacks batch-level FDA oversight of finished product<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">GLP-1 receptor agonists like semaglutide and tirzepatide produce 15\u201322% mean body weight reduction over 68\u201372 weeks by suppressing hypothalamic appetite signaling and slowing gastric emptying. Outcomes traditional dieting achieves in fewer than 8% of patients long-term.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Fat burning shot Vermont programs through TrimRx deliver compounded semaglutide or tirzepatide to any Vermont address within 48 hours via telehealth prescriptions from licensed providers. No in-person visits or insurance pre-authorization required.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Standard titration schedules take 20\u201324 weeks to reach therapeutic dose; patients notice appetite suppression within the first week but meaningful weight reduction (5%+) typically requires 8\u201312 weeks at maintenance dose.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Gastrointestinal side effects (nausea, vomiting, diarrhea) occur in 30\u201345% of patients during dose escalation and resolve within 4\u20138 weeks. Mitigation requires smaller meal sizes, lower fat intake, and slower titration if symptoms are severe.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Clinical trial data shows approximately 35% of patients are &#39;super responders&#39; losing more than 20% of body weight, while 10\u201315% lose less than 5% despite adherence. Response predictors include baseline insulin resistance and concurrent dietary structure.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Compounded semaglutide contains the same active molecule as brand-name Wegovy, prepared by FDA-registered 503B facilities under USP sterile compounding standards. It costs 60\u201385% less but lacks batch-level FDA oversight of the finished product.<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Fat Burning Shot Vermont Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What if I feel no appetite suppression after my first injection?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Continue the protocol. Starting doses (0.25mg semaglutide or 2.5mg tirzepatide) are sub-therapeutic and designed to allow receptor adjustment, not produce full efficacy. Most patients don&#39;t notice meaningful appetite reduction until reaching 1.0mg semaglutide or 7.5mg tirzepatide, typically 8\u201312 weeks into treatment. The absence of early-stage side effects doesn&#39;t predict non-response at therapeutic dose.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What if I miss a weekly injection \u2014 do I double the next dose?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">No. Never double-dose GLP-1 medications. If you miss a dose by fewer than five days, administer it as soon as you remember and resume your regular schedule. If more than five days have passed, skip the missed dose entirely and continue with your next scheduled injection. Missing doses during titration may cause temporary appetite rebound before the next administration, but doubling doses dramatically increases nausea and vomiting risk without improving efficacy.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What if I need to travel \u2014 can I take my medication through airport security?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Yes, but temperature management is critical. Compounded semaglutide stored as lyophilised powder tolerates ambient temperature (up to 25\u00b0C) for 24\u201348 hours, but once reconstituted with bacteriostatic water, it must stay refrigerated at 2\u20138\u00b0C. TSA permits medically necessary liquids in carry-on bags. Store your vial in an insulated medication cooler with ice packs and notify security during screening. Never check refrigerated medications in luggage; cargo holds can reach \u221220\u00b0C or 40\u00b0C depending on altitude and season.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Unfiltered Truth About Fat Burning Shot Vermont Access<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: most Vermont residents who would benefit from GLP-1 medications never start treatment. Not because they don&#39;t qualify medically, but because the traditional pathway (insurance pre-authorization \u2192 specialist referral \u2192 six-month waitlist \u2192 in-person titration visits every four weeks) creates so many friction points that people give up before the first injection. Insurance denial rates for weight loss indications exceed 70% even when patients meet BMI and comorbidity criteria, and appealing those denials takes 90\u2013120 days on average. By the time approval comes through, motivation has evaporated.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded semaglutide through 503B pharmacies bypasses this system entirely. It&#39;s not &#39;fake Ozempic&#39;. The active molecule is identical, prepared under the same USP &lt;797&gt; sterile compounding standards that hospitals use for IV medications. What it lacks is the FDA approval of the specific finished product manufactured by Novo Nordisk, which is granted to the formulation and delivery device, not the semaglutide molecule itself. The practical difference: if a batch is contaminated or incorrectly dosed, brand-name products trigger formal FDA recalls with patient notification; compounded products rely on state pharmacy board oversight and may not. For most patients, the 60\u201385% cost reduction and immediate access justify that tradeoff. Especially given the alternative is often no treatment at all.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">TrimRx operates explicitly in this gap. We don&#39;t accept insurance because insurance creates the delays and denials that prevent treatment. Licensed Vermont prescribers evaluate eligibility through a 15-minute telehealth consultation, write prescriptions for compounded semaglutide or tirzepatide, and coordinate direct shipment from FDA-registered 503B facilities to your Vermont address. Patients in Brattleboro, Bennington, and Barre receive medication within 48 hours and start treatment the same week they decide to pursue it. Our experience working with hundreds of patients in Vermont shows the single biggest predictor of long-term success isn&#39;t baseline BMI or comorbidity burden. It&#39;s removing logistical barriers to starting treatment before decision fatigue sets in.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The medication works. The clinical trial data is unambiguous. What doesn&#39;t work is a system that puts six months of administrative obstacles between a qualified patient and a weekly injection. If you&#39;ve tried structured dieting twice, lost weight both times, regained it within 18 months, and now meet BMI criteria (\u226530, or \u226527 with weight-related comorbidities like hypertension or prediabetes), the evidence supports pharmacological intervention. The question isn&#39;t whether GLP-1 medications are appropriate. It&#39;s whether you can access them before the next failed diet cycle erodes your belief that sustained weight loss is even possible. TrimRx exists because that timeline matters, and waiting six months for an in-person appointment in a state with 13 endocrinologists per 100,000 residents isn&#39;t a reasonable standard of care when telehealth and compounding pharmacies can deliver the same treatment this week.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Fat burning shot Vermont programs aren&#39;t experimental. They&#39;re the evidence-based standard that insurance bureaucracy and specialist scarcity have kept artificially inaccessible. If the clinical profile fits and the logistical barriers have been the only thing stopping you, those barriers no longer exist.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How does a fat burning shot work differently from dieting alone?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Fat burning shots using GLP-1 receptor agonists like semaglutide bind to receptors in the hypothalamus to suppress appetite signaling while slowing gastric emptying, creating sustained satiety without relying on willpower-driven restriction. This is mechanistically different from dieting: caloric restriction alone triggers compensatory hormonal responses \u2014 elevated ghrelin, suppressed leptin, reduced resting energy expenditure by 200\u2013400 calories daily \u2014 that work against long-term weight loss. GLP-1 medications interrupt this hormonal cascade, allowing patients to maintain deficits without the metabolic adaptation that makes sustained dietary restriction physiologically difficult. The STEP-1 trial showed 14.9% mean weight reduction at 68 weeks with semaglutide versus 2.4% with lifestyle counseling alone.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can Vermont residents get fat burning shots through telehealth without in-person visits?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 Vermont telehealth regulations permit licensed prescribers to evaluate patients, write prescriptions for GLP-1 medications, and coordinate shipment entirely remotely. TrimRx provides fat burning shot Vermont treatment through a fully remote platform: licensed Vermont prescribers conduct eligibility consultations via video, prescribe compounded semaglutide or tirzepatide, and ship medication to any Vermont address within 48 hours. No in-person visits, no insurance pre-authorization, no specialist referrals required. Patients in Burlington, Rutland, and Montpelier receive the same pharmaceutical-grade GLP-1 medications used in clinical trials without leaving home.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much does a fat burning shot cost in Vermont without insurance?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded semaglutide through 503B pharmacies costs approximately $250\u2013$400 monthly depending on dose tier, compared to $1,300\u2013$1,500 monthly for brand-name Wegovy at retail. Tirzepatide compounded costs $350\u2013$500 monthly versus $1,000\u2013$1,200 for brand-name Zepbound. TrimRx fat burning shot Vermont programs include the medication, telehealth consultations, and shipment in a single monthly fee starting at $297 \u2014 no insurance billing, no surprise charges. The 60\u201385% cost reduction reflects compounding pharmacy economics and the absence of brand-name markup, not inferior quality or different molecules.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What are the risks and side effects of fat burning shots?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Gastrointestinal side effects \u2014 nausea, vomiting, diarrhea, constipation \u2014 occur in 30\u201345% of patients during dose escalation and are the primary reason for discontinuation. These effects peak within 48 hours of each dose increase and typically resolve within 4\u20138 weeks. Serious adverse events include pancreatitis (0.2\u20130.4% incidence), gallbladder disease (1.5\u20132.5% incidence requiring cholecystectomy), and thyroid C-cell tumors (black box warning based on rodent studies; no confirmed human cases attributable to GLP-1 therapy as of 2026). Patients with personal or family history of medullary thyroid carcinoma or MEN2 syndrome are contraindicated. Standard mitigation: smaller meal sizes, lower fat intake, slower titration if symptoms are severe.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How long does it take to see weight loss results from fat burning shots?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Most patients notice appetite suppression within the first week at starting dose, but meaningful weight reduction \u2014 defined as 5% or more of body weight \u2014 typically takes 8\u201312 weeks at therapeutic dose (2.4mg semaglutide weekly or 10\u201315mg tirzepatide weekly). Standard titration schedules require 20\u201324 weeks to reach maintenance dose, meaning peak efficacy doesn&#8217;t occur until month five or six. Clinical trial data shows mean weight loss of 14.9% with semaglutide and 20.9% with tirzepatide at 68\u201372 weeks, but individual response varies significantly: approximately 35% of patients lose more than 20% of body weight while 10\u201315% lose less than 5% despite adherence.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is the difference between compounded semaglutide and brand-name Wegovy?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded semaglutide contains the same active molecule as brand-name Wegovy, prepared by FDA-registered 503B outsourcing facilities under USP sterile compounding standards. It is not &#8216;fake Ozempic&#8217; \u2014 the pharmacological mechanism and active ingredient are identical. What it lacks is the FDA approval of the specific finished formulation manufactured by Novo Nordisk, which is granted to the drug product, not the molecule itself. Compounded versions cost 60\u201385% less and are legally available when the FDA confirms a shortage of the branded product, which has been the case for semaglutide since 2023. The practical difference: batch-level FDA oversight applies to Wegovy but not to compounded preparations, which rely on state pharmacy board inspections.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Will I regain weight if I stop taking fat burning shots?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Clinical evidence shows most patients regain a significant portion of lost weight after discontinuing GLP-1 therapy \u2014 the STEP-1 Extension trial found participants regained approximately two-thirds of their lost weight within one year of stopping semaglutide. This reflects the fact that GLP-1 agonists correct a physiological state (impaired satiety signaling, elevated ghrelin) that returns when the medication is removed. For patients who achieve goal weight and wish to stop, transition planning \u2014 including structured dietary adjustments and, if appropriate, a lower maintenance dose (0.5\u20131.0mg semaglutide weekly) \u2014 can reduce rebound. GLP-1 medications are increasingly considered long-term metabolic management tools rather than short-term weight loss courses.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Who qualifies for fat burning shot treatment in Vermont?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Standard clinical criteria: BMI \u226530, or BMI \u226527 with at least one weight-related comorbidity (hypertension, type 2 diabetes, prediabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Patients must be 18+ years old. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2 (MEN2), pregnancy or planned pregnancy within six months, active pancreatitis, and severe gastroparesis. Licensed Vermont prescribers through TrimRx evaluate eligibility during a 15-minute telehealth consultation \u2014 approximately 75% of applicants who meet BMI criteria and have no contraindications are approved for treatment.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I use fat burning shots if I have type 2 diabetes?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 semaglutide and tirzepatide were originally developed and FDA-approved for type 2 diabetes management before receiving separate approvals for weight loss. Patients with type 2 diabetes often see dual benefits: HbA1c reduction of 1.5\u20132.0 percentage points alongside weight loss. However, dosing differs: diabetes-indication semaglutide (Ozempic) uses lower doses (0.5\u20132.0mg weekly) compared to weight loss dosing (Wegovy 2.4mg weekly). If you currently take insulin or sulfonylureas, starting a GLP-1 medication requires coordinated dose adjustments to prevent hypoglycemia \u2014 TrimRx prescribers review your current diabetes regimen and coordinate with your endocrinologist or primary care provider to ensure safe titration.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How do I store fat burning shot medication correctly?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded semaglutide or tirzepatide arrives as either lyophilised powder or pre-mixed solution. Lyophilised powder stores at \u221220\u00b0C before reconstitution; once mixed with bacteriostatic water, refrigerate at 2\u20138\u00b0C and use within 28 days. Pre-mixed pens or vials must remain refrigerated at 2\u20138\u00b0C at all times \u2014 any temperature excursion above 8\u00b0C for more than 2\u20134 hours causes irreversible protein denaturation that neither appearance nor home potency testing can detect. Never freeze reconstituted medication; ice crystal formation ruptures peptide structure. If traveling, use an insulated medication cooler with ice packs and keep medication in carry-on luggage \u2014 checked baggage cargo holds reach temperatures that destroy GLP-1 medications.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fat burning shots using GLP-1 medications like semaglutide deliver medically supervised weight loss in Vermont through telehealth prescriptions shipped<\/p>\n","protected":false},"author":6,"featured_media":88317,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Fat Burning Shot Vermont \u2014 GLP-1 Weight Loss Injections","_yoast_wpseo_metadesc":"Fat burning shots using GLP-1 medications like semaglutide deliver medically supervised weight loss in Vermont through telehealth prescriptions shipped","_yoast_wpseo_focuskw":"fat burning shot vermont","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-88318","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/88318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=88318"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/88318\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/88317"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=88318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=88318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=88318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}